← All trials
NCT04786938
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 7, 2016
- Primary completion
- Jun 9, 2017
- Completion date
- Jun 9, 2017
- First posted
- Mar 8, 2021
- Last posted
- Oct 4, 2021
- Enrollment
- 72
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidad San Francisco de QuitoLead sponsor
- BiocodexCollaborator
- Universidad San Francisco de QuitoReponsible party - principal investigator
- Universidad San Francisco de QuitoOverall official - principal investigator
- Universidad Tecnológica EquinoccialCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.